Orthofix Q2 FY26 net loss widens to USD 15.8 million; net sales rise 4% to USD 210.9 million
OFIX•Orthofix reports higher sales but wider loss in Q2 FY26
- Orthofix posted Q2 net sales of USD 210.9 million, up 4% from a year earlier.
- Net loss widened to USD 15.8 million, or USD 0.39 a share.
- Non-GAAP adjusted EBITDA edged down to USD 20.1 million, from USD 20.6 million.
- Cash, cash equivalents and restricted cash fell to USD 104.4 million, due to arbitration award and settlement payments.
- The company raised its 2026 net sales outlook to USD 845 million-USD 855 million and lifted its non-GAAP adjusted EBITDA view to USD 95 million-USD 98 million.
